Floatz logo

CBL-0137 FREE BASE

Advanced Sarcoma of the Extremity

Roswell Park Cancer InstituteSmall moleculePhase 1Dormant
CC
41/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
26/ 100
Competitive Position
95/ 100

Competitive context

110 Active assets in the Advanced Sarcoma of the Extremity cohort.

Asset / SponsorPhaseRating
ETOPOSIDE
National Cancer Institute (NCI)
Phase 2BB
Cyclophosphamide
Essen Biotech
Phase 2BB
Ifosfamide
City of Hope Medical Center
Phase 3BB
Inno-206
City of Hope Medical Center
Phase 3BB
Carboplatin
OHSU Knight Cancer Institute
Phase 2BB

View all 50 →

Same molecule, other indications

CBL-0137 FREE BASE is also rated in:

Metastatic Malignant Neoplasm in the Central Nervous SystemDormant
CC
Indicative ·
44 / 100
View asset →
diffuse midline glioma, H3 K27-alteredDormant
CC
Indicative ·
44 / 100
View asset →
diffuse intrinsic pontine gliomaDormant
CC
Indicative ·
44 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →